News from the FDA/CDC
News from the FDA/CDC
CDC: Thirty percent of hospital workers in U.S. still unvaccinated
Health care personnel “are not fully immune from vaccine misinformation.”
News
CDC endorses Pfizer’s COVID-19 vaccine for young kids
No cases of myocarditis were seen in the studies, but myocarditis is a very rare side effect, and the studies were too small to pick up these...
News from the FDA/CDC
COVID-19 vaccines provide 5 times the protection of natural immunity, CDC study says
“We now have additional evidence that reaffirms the importance of COVID-19 vaccines, even if you have had prior infection.”
News
FDA panel votes to approve Pfizer’s vaccine for children
If the FDA follows the recommendation, as it typically does, ...the shots could be available within days.
News from the FDA/CDC
CDC panel backs COVID-19 boosters for nearly all adults
News from the FDA/CDC
Adalimumab biosimilar Cyltezo gets interchangeability designation
The approval of the supplemental biologics license application for Cyltezo makes the adalimumab biosimilar just the second biosimilar to be...
News from the FDA/CDC
FDA approves avacopan for rare ANCA autoimmune disease
ChemoCentryx said it plans to price its new medicine at an annual cost of $150,000-$200,000 for U.S. patients.
News from the FDA/CDC
Johnson & Johnson requests FDA approval for vaccine booster doses
The FDA’s independent vaccine advisory committee meets next week to review data on booster shots from both Johnson & Johnson and Moderna.
News from the FDA/CDC
FDA issues proposed order for over-the-counter sunscreens
“Sprays will be considered for [generally recognized as safe] status so long as properly tested, labeling should be clearer … and bug spray–...
Latest News
CDC chief overrules panel, OKs boosters for health care workers
Panelists “did not buy the need in occupational or institutional settings.”
News
FDA approves topical ruxolitinib for atopic dermatitis, first JAK inhibitor for this indication in the U.S.
“Approval of topical ruxolitinib fills a major gap in the treatment of atopic dermatitis: a safe, effective, and tolerable non-steroidal topical...